$DOC

Healthpeak Properties (DOC) declared monthly dividends totaling $1.22004 annually, with a 6.48% yield. Shares fell 8.36% to $18.83. Q2 2026 revenue was $310.67M for outpatient, $216.11M for lab, and senior housing showed growth. FFO guidance is $1.73-$1.77, covering the dividend. Asset sales and recapitalizations raised $1.75B. Peers Welltower (WELL) and Ventas (VTR) raised dividends. DOC's payout ratio is 69.7% at midpoint. Interest expenses rose to $92.3M.

Healthpeak Properties (DOC) declared a monthly dividend of $0.10167 per share for Q4 2026, equating to an annualized dividend of $1.22 per share. This maintains the company's regular monthly dividend schedule.

Healthpeak Properties (DOC), an S&P 500 healthcare REIT, pays a monthly dividend of $0.10 per share, yielding 6%. The stock has risen 27.5% in 2026, with strong Q1 and Q2 earnings. Management raised FFO guidance to $1.73-$1.77 per share. Analysts' average price target is $23. Rising interest rates pose a risk to REITs.

Healthpeak Properties (DOC) raised its 2026 guidance, citing strong performance in outpatient medical and lab leasing, and significant growth at its senior housing operator, Janus Living (JAN). The company reported $0.46 FFO per share, flat year-over-year, and used asset sales to reduce debt and fund buybacks. Lab segment NOI declined, and leverage remains at 4.7x EBITDAre.

DO & CO reported Q1 FY26/27 results despite Middle East headwinds. Sales rose 5% to €642m and EBIT rose 8% to €57m, margin 8.8%. Net profit increased 16% to €31m. Management said conflict-related costs reduced sales by about €40m. FY26/27 targets are 6-8% sales growth with EBIT margin 8.6-9.0%.

Healthpeak Properties (NYSE:DOC) highlighted Q2 results and updates on capital recycling and leasing. It recapitalized a Brookfield outpatient portfolio, retaining 51% interest and raising $1B cash, and noted a 5.9% trailing cash cap rate. Lab occupancy rose to 78.5%. Net debt/adj. EBITDA was 4.7x with $4.1B liquidity; it repaid $900M debt and repurchased $100M shares.

Healthpeak Properties (DOC) is a U.S. healthcare REIT with a $14.9B market cap. The stock rose 31.8% over the past year and nearly 41% in 2026. After Q2 2026 results on Aug. 4, revenue was $771.6M and adjusted FFO was $0.46, both above estimates. Full-year FFO guidance is $1.73 to $1.77. Analysts rate DOC a “Moderate Buy,” with Barclays holding a $23 target.

HEALTHPEAK PROPERTIES, INC. (DOC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Healthpeak Properties Reports Second Quarter 2026 Results and Increases Full Year 2026 Earnings Guidance DENVER, August 4, 2026 - Healthpeak Properties, Inc. (NYSE: DOC) ("Healthpeak"), a leading owner, operator, and developer of real estate for healthcare discovery

Brookfield Asset Management and its affiliates formed a joint venture with Healthpeak Properties to obtain a 49% interest in Healthpeak’s 86 outpatient medical buildings nationwide, valued at about $2.1B. The portfolio totals about 5.6M sq ft across 11 states and is 95% leased, per the announcement. Healthpeak keeps 51% control and received about $1B in gross proceeds.

Brookfield Asset Management will form a U.S. outpatient medical buildings joint venture with Healthpeak Properties. Healthpeak will contribute 86 properties valued at about US$2.1 billion. Brookfield and affiliates will hold 49% and receive about US$1.03 billion in gross proceeds, while Healthpeak holds 51% and manages. The portfolio is 95% leased across 11 states.